IMiDs stimulate T cell proliferation and cytokine secretion, decrease the expression of PD-1 on both T and NK cells in MM patients, as well as decrease both PD-1 and PD-L1 on MM cells. This evidence concerns the gene PDCD1 and Miyoshi myopathy.